Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: A population-based study of older individuals in Spain by Gijón-Conde, Teresa et al.
  
 
 
Repositorio Institucional de la Universidad Autónoma de Madrid 
https://repositorio.uam.es  
Esta es la versión de autor del artículo publicado en: 
This is an author produced version of a paper published in: 
 
    Hypertension Research 40.6 (2017): 613-619 
 
DOI:    http://doi.org/10.1038/hr.2017.9 
 
Copyright: © 2017 The Japanese Society of Hypertension 
 
El acceso a la versión del editor puede requerir la suscripción del recurso 
Access to the published version may require subscription 
 
1 
 
Short-term variability and nocturnal decline in ambulatory blood pressure in 
normotension, white-coat hypertension, masked hypertension, and sustained 
hypertension: a population-based study of older individuals in Spain 
Running title: Ambulatory blood pressure variability   
Authors:   
Teresa Gijón-Conde 1, 2 Auxiliadora Graciani1, Esther López-García1, Pilar Guallar-
Castillón1, Esther García-Esquinas1, Fernando Rodríguez-Artalejo1, José R. Banegas1  
Authors’ affiliations:  
1Department of Preventive Medicine and Public Health, School of Medicine, 
Universidad Autónoma de Madrid ⁄ IdiPAZ – CIBER in Epidemiology and Public 
Health (CIBERESP), Madrid, Spain. 
2Centro de Salud Universitario Cerro del Aire, Majadahonda, Madrid, Spain 
Correspondence: José R. Banegas, MD or Teresa Gijon, MD, Department of 
Preventive Medicine and Public Health, Universidad Autónoma de Madrid, Arzobispo 
Morcillo 2, 28029 Madrid, Spain. E-mail: joseramon.banegas@uam.es 
Financial support. Study partially funded by FIS grant PI13/02321 and PI16/01460 
(Instituto de Salud Carlos III and FEDER/FSE) and CIBERESP.  
Word count: 3010 (excluding references). Number of references: 52. Number of tables: 
4, Number of figures: 0  
2 
 
ABSTRACT 
Blood pressure (BP) variability and nocturnal decline in blood pressure are associated 
with cardiovascular outcomes. However, little is known about whether these indexes are 
associated with white-coat and masked hypertension. We performed a cross-sectional 
analysis of 1047 community-dwelling individuals aged ≥60 years in Spain in 2012. 
Three observer-measured home BPs and 24-hour ambulatory blood pressure monitoring 
(ABPM) were performed under standardized conditions. BP variability was defined as 
BP standard deviation and coefficient of variation. Differences in BP variability and 
nocturnal BP decrease between groups were adjusted for sociodemographic and clinical 
covariates using generalized linear models. Of the cohort, 21.7% had white-coat 
hypertension, 7.0% had masked hypertension, 21.4% had sustained hypertension, and 
49.9% were normotensive. Twenty-four hour, daytime, and nighttime systolic BP 
standard deviations and coefficients of variation were significantly higher in subjects 
with white-coat hypertension than those with normotension (p<0.05) and were similar 
to subjects with sustained hypertension. In untreated subjects, 24-hour but not daytime 
or nighttime BP variability indexes were significantly higher in subjects with white-coat 
hypertension than in those with normotension (p<0.05). Percentage decrease in 
nocturnal systolic and diastolic BP was greatest in the white-coat hypertension group 
and lowest in the masked hypertension group in all patients and untreated patients 
(p<0.05). Lack of nocturnal decline in systolic blood pressure was observed in 70.2% of 
subjects with normotension, 57.8% of subjects with white-coat hypertension, 78.1% of 
subjects with masked hypertension, and 72.2% of subjects with sustained hypertension 
(p<0.001). In conclusion, 24-hour BP variability was higher in subjects with white-coat 
hypertension and blunted nocturnal BP decrease was observed more frequently in 
subjects with masked hypertension. These findings may help to explain the reports of 
increased cardiovascular risk in patients with white-coat hypertension and poor 
prognosis in those with masked hypertension, highlighting the importance of ABPM.  
 
Key words: aged, blood pressure variability, masked hypertension, population studies, 
white coat hypertension  
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INTRODUCTION 
Conventional measurement of blood pressure (BP) in a medical office is the standard 
method for the diagnosis and management of hypertension. However, there are several 
limitations to this approach, including apparently innocent elevations of BP that only 
occur in the clinic (white-coat hypertension) or the observation of normal readings 
when, in fact, the patient is hypertensive (masked hypertension).1, 2 Numerous reports of 
a wide variety of conditions and populations have demonstrated that ambulatory BP 
monitoring (ABPM) is superior to office-based measurement with respect to 
cardiovascular risk assessment.3,4  
BP not only exhibits large circadian variations in terms of changes between day 
and night but also changes from minute-to-minute and hour-to-hour in both 
hypertensive and normotensive patients.5 Thus, non-invasive 24-hour ABPM is a robust 
method to assess short-term BP variability within 24 hours.6   
Most studies have found that high 24-hour BP variability is associated with 
organ damage and may contribute to cardiovascular risk prediction, over and beyond 
mean BP.7-17 However, the degree to which variability improves the prediction of 
cardiovascular risk is controversial.18–20 Previous studies have shown that nighttime BP 
is generally a better predictor of cardiovascular outcomes than daytime BP in patients 
with hypertension, and diminished nocturnal decline in BP is associated with or 
predictive of organ damage and cardiovascular events.21-26  
Only a few studies have analyzed whether different phenotypes on the 
hypertension spectrum such as normotension, white-coat hypertension, masked 
hypertension, and sustained hypertension are associated with BP variability independent 
of mean BP.27,28 As far as we know, there are no reports about circadian variability and 
BP variability in daytime and nighttime periods across the various BP phenotypes. It is 
possible that the reported increases in cardiovascular risk in patients with white-coat 
hypertension or masked hypertension2 could be attributed, at least in part, to BP 
variability and nocturnal decline in BP. The objective of this study was to describe the 
relationships between mean daytime and nighttime ambulatory BP, BP variability, and 
nocturnal decline in BP with subjects with normotension and white-coat, masked, and 
sustained hypertension in a cross-sectional analysis of older adults in Spain.29  
 
METHODS  
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Study Design and Population  
Data are taken from the Seniors-ENRICA cohort, and the methods have been previously 
reported.29,30 In brief, this cohort was established in 2008-2010 with 2614 individuals 
selected through stratified random sampling from the population of individuals in Spain 
aged ≥60 years.29 Baseline information on sociodemographic variables, lifestyle, health 
status, and morbidity was collected by telephone interview. In addition, a home visit 
was conducted to collect blood samples, and another home visit was conducted to 
perform a physical examination and to record dietary habits and prescribed medications. 
Participants were followed until 2012, when a second wave of data collection was 
performed. At this time point, of the 2519 surviving subjects, 2037 provided updated 
information for the telephone interview, physical examination, diet, and medication. 
ABPM was offered to 1698 individuals in this second wave for cost and logistical 
reasons, and the analysis was performed in 1328 subjects (response rate, 78.2%). The 
subjects who underwent ABPM had similar characteristics to those who did not in terms 
of age, sex, education level, obesity, diabetes, current smoking, and previous history of 
cardiovascular disease.  
Personnel involved in data collection received specific training in the study 
procedures. Study participants gave written informed consent. The study was approved 
by the Clinical Research Ethics Committee of the “La Paz” University Hospital in 
Madrid.  
Study Variables  
Study participants reported their age, sex, and smoking status. Weight and height were 
measured in each subject under standardized conditions. Body mass index (BMI) was 
calculated as weight in kilograms divided by the square of the height in meters. Study 
subjects reported whether they had been previously diagnosed with 
hypercholesterolemia or cardiovascular disease (myocardial infarction, stroke, heart 
failure). Diabetes mellitus was identified as fasting serum glucose ≥126 mg/dL or 
treatment with oral antidiabetic drugs or insulin. Medication use was assessed by a face-
to-face interview and verified against drug packaging during the home visits.  
Blood pressure measurement  
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BP was measured using standardized procedures and conditions, with validated 
automatic devices (Omron M6) and appropriate-sized cuffs. Trained observers 
measured each participant’s BP during a home visit: three measurements were taken at 
two-minute intervals after resting for five minutes in a seated position. In the analyses, 
BP was calculated as the mean of the last two of the three readings. Thereafter, 24-hour 
ABPM was performed using a validated automated non-invasive oscillometric device 
(Microlife® WatchBPO3 monitor),31 programmed to measure BP at 20-min intervals 
during the day and at 30-min intervals during the night for a 24-hour period. 
Appropriate cuff sizes were used. The majority of measurements were performed on 
working days, and the patients were instructed to maintain their usual activities but keep 
the arm extended and immobile at the time of cuff inflation. Valid ABPM 
measurements had to fulfill several pre-established criteria, including 24-hour duration 
and at least 70% of systolic BP (SBP) and diastolic BP (DBP) successful recordings 
during the daytime and nighttime periods.1,2,32 Daytime and nighttime periods were 
defined individually according to the patient’s self-reported time of going to bed and 
waking up. Based on international guidelines,1,2,32 white-coat hypertension was defined 
as conventional BP ≥140/90 mm Hg and 24-hour ABPM <130/80 mm Hg; masked 
hypertension was defined as conventional BP <140/90 mm Hg and 24-hour ABPM 
≥130/80 mm Hg; sustained hypertension was defined as conventional BP ≥140/90 mm 
Hg and 24-hour ABPM ≥130/80 mm Hg; normotension was defined as conventional BP 
<140/90 mmHg and 24-hour ABPM <130/80 mmHg. We have used these terms for the 
sake of simplicity. However, among untreated patients, the terms normotension, white-
coat hypertension, masked hypertension, and sustained hypertension would be more 
correct, and among treated patients, the terms controlled hypertension, white-coat 
uncontrolled hypertension, masked uncontrolled hypertension, and uncontrolled 
hypertension would be appropriate. Short-term variability was assessed by the standard 
deviation (SD) and the coefficient of variation (CV) [standard deviation/mean×100%] 
of SBP and DBP in 24 hour, daytime, and nighttime periods. Nocturnal decrease in SBP 
and DBP was measured in both absolute terms (mmHg) and relative terms and as BP 
dipping (nondipping was defined as nocturnal BP decrease <10% of daytime BP).1,2,32  
Statistical analyses  
For descriptive analysis, we used the mean and standard deviation for continuous 
variables and the percentage distribution of frequencies for categorical variables. To 
6 
 
compare means between groups, we used Student’s t-test and analysis of variance. For 
comparison of percentages, the chi-square test was used.  
Mean ambulatory BPs, BP variability indexes, and nocturnal decrease in BP 
were compared between BP phenotypes using generalized linear model analyses, 
adjusting for age, sex, BMI, smoking, diabetes, dyslipidemia, previous cardiovascular 
diseases, antihypertensive treatment (yes/no), and mean ambulatory SBP or DBP 
according to the time period, as appropriate. We also performed a separate analysis of 
mean ambulatory BPs and BP variability indexes in untreated subjects. Lastly, we 
analyzed the percentage reduction of nocturnal BP according to treatment status and 
adjusted for the covariates listed above. The Bonferroni correction was used for post 
hoc multiple comparisons. Statistical significance was established at p<0.05. The 
Statistical Package for Social Sciences (SPSS) for Windows version 19.0 software 
(SPSS Inc., IBM, Armonk, NY) was used for statistical analysis.  
RESULTS 
A total of 1047 individuals (mean age 71.7 years, 50.8% men) with ≥70% valid ABPM 
readings and complete information on the study variables were used for analysis (80% 
of all individuals with available ABPM). The mean conventional SBP/DBP was 
137.8/74.0 mmHg, and the mean BMI was 27.8 kg/ m2; 49.5% of subjects had 
hypercholesterolemia, 14.9% had diabetes, 5.7% had cardiovascular disease, and 42.9% 
were treated with an antihypertensive medication (Table 1). After ABPM, the global 
distribution of subjects was as follows: 49.9% had normotension (or controlled 
hypertension in treated subjects), 21.7% had white-coat hypertension (or white-coat 
uncontrolled hypertension in treated subjects), 7.0% had masked hypertension (or 
masked uncontrolled hypertension in treated subjects), and 21.4% had sustained 
hypertension (or uncontrolled hypertension in treated subjects) (Table 1).  
After adjusting for demographic and clinical covariates (including mean 
ambulatory BP and antihypertensive treatment), systolic and diastolic 24-hour BP 
variability indexes were significantly higher in individuals with white-coat hypertension 
than in those with normotension (Table 2). As expected, mean systolic and diastolic 24-
hour BPs were higher in subjects with masked hypertension relative to subjects with 
white-coat hypertension. We did not observe any differences between 24-hour BP 
variability indexes in subjects with masked vs. white-coat hypertension or between 
subjects with sustained vs. masked hypertension. During the daytime, systolic BP 
7 
 
variability indexes were higher in individuals with white-coat hypertension than in those 
with normotension. No differences between diurnal BP variability indexes were 
observed between subjects with masked vs. white-coat hypertension or sustained vs. 
masked hypertension. During the night, systolic BP variability indexes were higher in 
individuals with white-coat hypertension relative to those with normotension. We 
observed no differences in systolic and diastolic BP variability indexes in subjects with 
sustained vs. masked hypertension or masked vs. white-coat hypertension. Furthermore, 
no differences were observed in nighttime mean systolic and diastolic BP in subjects 
with sustained vs. masked hypertension. Table 3 shows mean systolic and diastolic 24-
hour pressures, day and night mean BPs, and BP variability indexes in untreated 
subjects. Notably, we observed a significant difference in mean 24-hour BPs and 24-
hour variability indexes in subjects with white-coat hypertension vs. normotension, 
similar to our observations in the cohort as a whole. However, we did not observe any 
differences in day and night BP variability indexes between subjects with different 
hypertension phenotypes.  
The proportion of systolic non-dipping was 70.2% (95% confidence interval 
(CI): 66.0% to 74.0%) in subjects with normotension, 57.8% (95% CI: 51.6% to 63.8%) 
in subjects with white-coat hypertension, 78.1% (95% CI: 66.6% to 86.5%) in subjects 
with masked hypertension, and 72.2% (95% CI: 66.1% to 77.6%) in subjects with 
sustained hypertension (p<0.001). The proportion of diastolic non-dipping was 51.0% 
(95% CI: 46.6% to 55.4%) in subjects with normotension, 35.7% (95% CI: 30.0% to 
41.8%) in subjects with white-coat hypertension, 64.1% (95% CI: 51.8% to 74.7%) in 
subjects with masked hypertension, and 50.0% (95% CI: 43.6% to 56.3%) in subjects 
with sustained hypertension (p<0.001). These differences were maintained in untreated 
subjects but not in treated subjects (data not shown).  
Table 4 shows the percentage decrease in nocturnal systolic and diastolic BP 
according to antihypertensive treatment status and adjusted for demographic and clinical 
covariates. In the whole cohort, as well as untreated patients, the relative reduction in 
systolic and diastolic BP was greatest in subjects with white-coat hypertension and 
lowest in those with masked hypertension. Significant differences were observed in 
subjects with white-coat hypertension vs. normotension, masked vs. white-coat 
hypertension, and sustained vs. masked hypertension (p <0.05).  
 
DISCUSSION 
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This study performed in a cohort of community-dwellers in Spain aged ≥60 years found 
the following: i) a higher ambulatory 24-hour BP variability in individuals with white-
coat hypertension than in those with normotension (and similar to that in those with 
sustained hypertension), and (ii) diminished rates of nighttime BP dipping and a higher 
proportion of non-dipping in subjects with masked hypertension than those with 
normotension, independent of important sociodemographic and clinical covariates. 
These results were only maintained when untreated patients were considered. These 
findings may be pertinent to the reports that patients with white-coat hypertension have 
higher cardiovascular risk than those with normotension.33-35 Furthermore, the 
observation that those patients with masked hypertension have a worse prognosis than 
those with white-coat hypertension could be partly explained by both the higher mean 
ambulatory BPs at all time periods (including sleeping) and the diminished nocturnal 
BP dip. This reinforces the importance of ABPM as a helpful tool to establish the 
diagnosis and prognosis of BP phenotypes. To the best of our knowledge, no previous 
studies have focused on these relationships including overnight examination.  
The reported frequency of white-coat and masked hypertension ranges from 10 
to 50%36 depending on the cut-offs used for normal ambulatory BP and the study 
population. Thus, the apparent low frequency of white-coat and masked hypertension in 
our study (21.7% and 7.0%, respectively) is noteworthy in comparison to other studies 
that included thresholds of 140/90 mmHg for clinic BP and 135/85 mmHg in daytime 
BP36 but that ignored the nighttime period. Such an omission may lead to 
overestimation of the frequency of white-coat and masked hypertension. We have used 
140/90 mmHg as a threshold for observer-measured home BP and 130/80 mmHg in 24-
hour ambulatory BP that included nocturnal BP values and could thus be considered a 
relatively exigent scenario. Although any time interval suffices to diagnose masked 
hypertension, as proposed in current guidelines, full 24-hour recordings remain 
standard in clinical practice.37 The higher 24-hour BP variability in subjects with white-
coat hypertension may help to explain the higher rates of cardiovascular risk that have 
been reported in previous studies of these patients.33-35 BP variability depends on 
sympathetic vascular modulation and changes in arterial distensibility. Higher short-
term BP variability in subjects with white-coat hypertension than in those with 
normotension has been reported in a few other studies38,39 and may be intrinsic or an 
enhanced stress response to external stimuli. Alternatively, it may reflect a diffuse 
atherosclerotic process induced by aging and hypertension that leads to increased 
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stiffness of the large elastic arteries and/or depressed baroreflex functions causing 
impaired cardiovascular control mechanisms.5 In addition, we postulate that 
mechanisms other than sympathetic activity are operating in white-coat hypertension, 
since this activity correlates with the level and standard deviation of BP, but not with 
the coefficient of variation, a measure of variability that is less dependent on the level 
of BP than the standard deviation.40 It is noteworthy that in patients with 
antihypertensive treatment, we did not observe any differences in BP variability 
indexes. So, it is possible that antihypertensive treatment controls BP variability 
independent of mean BP. This may be a future target for controlling BP. 
There is strong evidence that patients with masked hypertension are at increased 
risk of target organ damage and cardiovascular morbidity,2,41,42 with an overall 
cardiovascular risk approaching that of patients with sustained hypertension.43 In our 
study, the higher level of mean nighttime BP in patients with masked hypertension (vs. 
those with white-coat hypertension or normotension and no difference when compared 
to those with sustained hypertension) may also explain the poorer prognosis of patients 
with masked hypertension in comparison with those with white-coat hypertension. This 
is in line with several observational and longitudinal analyses demonstrating the 
superior value of nocturnal BP compared with daytime BP in predicting cardiovascular 
events and all-cause mortality.19,24,43 Nocturnal BP at resting conditions is the minimum 
BP needed for adequate organ perfusion, and high BP at night could overload the 
cardiovascular system and lead to negative effects on the heart and vascular structures.44 
Mentally stressful situations have been associated with masked hypertension and high 
BP variability.45   
In this study, the high frequency of systolic and diastolic nondipping and the 
significant decrease in nocturnal BP decline in patients with masked hypertension after 
adjusting for ambulatory BP levels, antihypertensive drug treatment, and other 
covariates could help to explain why patients with masked hypertension have a poor 
prognosis. It has been reported that nondipping and diminished decline in nocturnal BP 
is associated with organ damage and poor cardiovascular outcomes both in population 
studies and in hypertensive patients.46-49 It is noteworthy that in patients with 
pharmacological treatment, we did not observe any differences in nocturnal BP declines 
between groups. So, it is possible that antihypertensive treatment may affect nocturnal 
BP decline independent of mean BP. This may be a target for future BP control. 
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Nighttime masked hypertension is observed in various conditions that produce 
non-dipping status, including high salt intake, renal dysfunction, obesity, sleep apnea, 
and autonomic failure.50 In particular, investigation of nocturnal BP and decline in 
nocturnal BP using ABPM suggest that this process is salt sensitive, which is associated 
with increased sympathetic activity and increased cardiovascular risk.51 Nondipping 
could reflect an inadequacy of the mechanisms regulating BP; it could be the result of 
baroreflex or autonomic dysfunction, relative nocturnal volume overload, or abnormal 
sodium handling. ABPM can refine the prognostic assessment in hypertension not only 
by providing an accurate BP value that is the average of a large number of BP 
measurements but also by assessing circadian variability, a parameter which requires 
ABPM.44  
Given that this study was not strictly representative of the general older 
population of Spain, extrapolations should be interpreted with caution. Nevertheless, the 
baseline sociodemographic and clinical characteristics of the participants were similar to 
those who did not participate. It should be noted that in this study, conventional BP was 
not measured in the office or clinic but in subjects’ homes as in other studies,52 thereby 
decreasing the effect of anxiety and giving more realistic estimates. Nevertheless, we 
used the 140/90 mmHg target for the primary analysis of conventional BP, since BP 
was measured on only one occasion and involved a technique similar to that used for 
office BP measurements. Furthermore, although white-coat and masked hypertension 
are not entirely accurate terms and “isolated home BP elevation” or “isolated 
ambulatory BP elevation,” are more appropriate and descriptive terms, we have 
maintained the terms “white coat” and “masked” hypertension for the sake of clarity 
and comparison with other studies. Lastly, determination of antihypertensive therapy 
was based on the participant’s self-report and may, therefore, be inaccurate; however, 
medications were checked against prescription containers. Lastly, the cross-sectional 
design prevents us from assessing causal relationships between the associations we 
report.  
In conclusion, we found that 24-hour BP variability was higher in subjects with 
white-coat hypertension than in normotensive individuals and that non-dipping was 
higher, with diminished decline in nocturnal BPs, in subjects with masked hypertension. 
These findings may help to explain the reports of higher cardiovascular risk in patients 
with white-coat hypertension and the poor prognosis observed in patients with masked 
hypertension, highlighting the clinical diagnostic and prognostic utility of ABPM. 
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Future research should evaluate the causal relationship between ambulatory BP 
variability and white-coat hypertension and between diminished nocturnal decreases in 
BP and masked hypertension.  
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